Weiqin Lin
Overview
Explore the profile of Weiqin Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
271
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lee A, Yau C, Low C, Li J, Tyebally S, Lin W, et al.
Cancers (Basel)
. 2023 Jan;
15(2).
PMID: 36672461
Background: Anthracyclines form the backbone of many systemic chemotherapy regimens but are accompanied by dose-limiting cardiotoxicity. We elucidate the progression and severity of cardiac function over time, in the absence...
12.
Varghese L, Lin W, Linden S, Lum A, Sim D
Value Health Reg Issues
. 2023 Jan;
34:108-117.
PMID: 36669346
Objectives: The prevalence of heart failure (HF) and its risk factors are high in Singapore. The EMPEROR-Reduced trial demonstrated that add-on empagliflozin resulted in a reduction in the risk of...
13.
Tan S, Low C, Ng W, Ling R, Tan C, Lim S, et al.
Life (Basel)
. 2022 Oct;
12(10).
PMID: 36295065
Microaxial left ventricular assist devices (LVAD) are increasingly used to support patients with cardiogenic shock; however, outcome results are limited to single-center studies, registry data and select reviews. We conducted...
14.
Ye T, Siah Q, Tan B, Ho J, Syn N, Teo Y, et al.
J Thromb Thrombolysis
. 2022 Oct;
55(1):83-91.
PMID: 36192663
Hypertrophic cardiomyopathy predisposes to acute cerebrovascular events including ischaemic stroke, transient ischaemic attack and systemic thromboembolism. Atrial fibrillation confers even higher risk. We aim to report the incidence of these...
15.
Tan S, Ho C, Teo Y, Teo Y, Chan M, Lee C, et al.
Front Cardiovasc Med
. 2022 Oct;
9:967197.
PMID: 36186994
Introduction: Heart failure (HF) is associated with ischemic stroke (IS). However, there are limited studies on the prevalence of IS, white matter hyperintensities (WMHs), and silent brain infarcts (SBIs). Furthermore,...
16.
See A, Ho J, Chan M, Lim Y, Yeo T, Chai P, et al.
Heart Lung Circ
. 2022 Sep;
31(11):1450-1462.
PMID: 36137915
Aims: Heart failure (HF) is one of the leading causes of mortality worldwide. Heart failure is also one of the most common presentations of cardiac amyloidosis (CA). Contemporary epidemiological data...
17.
Wong M, Wong R, Lim Y, Sia C, Evangelista L, Singh D, et al.
Ann Acad Med Singap
. 2022 Jul;
51(7):436-440.
PMID: 35906942
No abstract available.
18.
Yap N, Kor Q, Teo Y, Teo Y, Syn N, Evangelista L, et al.
Hellenic J Cardiol
. 2022 Jul;
67:48-58.
PMID: 35839985
Introduction: The burden of cognitive impairment in heart failure (HF) patients is significant and leads to longer hospital stay, higher readmission rates, and increased mortality. This review seeks to synthesize...
19.
Lin W, Chattranukulchai P, Lee A, Lin Y, Yu W, Liew H, et al.
Clin Cardiol
. 2022 Jul;
45(9):898-907.
PMID: 35795903
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a debilitating and life-threatening condition with a heterogeneous clinical presentation. Recent guidelines from the United States and Europe have been published to guide clinical practice...
20.
Ng P, Lim Y, Evangelista L, Wong R, Chai P, Sia C, et al.
Ann Noninvasive Electrocardiol
. 2022 May;
27(4):e12967.
PMID: 35567784
Background: Cardiac amyloidosis is a protein misfolding disorder involving deposition of amyloid fibril proteins in the heart. The associated fibrosis of the conduction tissue results in conduction abnormalities and arrhythmias....